Evaluation of Anticancer Activity of 1,3-Oxazol-4-ylphosphonium Salts in Vitro.

Publication Year: 2022

DOI:
10.1002/cmdc.202200319

PMCID:
PMC9825890

PMID:
36037305

Journal Information

Full Title: ChemMedChem

Abbreviation: ChemMedChem

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pharmacology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of interest The authors declare no conflict of interest."

Evidence found in paper:

"We would like to thank the US Public Health Service and the National Cancer Institute, Bethesda, MD, USA, for in vitro evaluation of anticancer activity (providing the NCI‐60 cell testing) within the framework of Developmental Therapeutic Program (http://dtp.cancer.gov), and Enamine Ltd for the material and technical support. These studies are partially funded by the National Research Foundation of Ukraine (2020.01/0075 NRFU competition “Science for the Security of Human and Society”). Ye. V. thanks INSA Rouen Normandie and the Région Normandie for financial support."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025